abstract |
The present invention relates to new derivatives of 1-benzyl-3-hydroxymethylindazole according to formula (I) described in the claims, and a pharmaceutical composition containing them together with a pharmaceutically acceptable excipient. In addition, the present invention relates to the use of new derivatives of 1-benzyl-3-hydroxymethylindazole to obtain a pharmaceutical composition that is active in the treatment of diseases caused by the expression of MCP-1 and CX3CR1, and their use in a method of treating or preventing diseases caused by the expression of MCP -1 and CX3CR1. |